Similar Items: The development of a radiolabelled macromolecule as a therapeutic agent for the treatment of cancer
- Novel chemotherapeutic agents for oesophageal cancer
- Investigating the nuclear import protein KPn߀1 as a cancer therapeutic target
- South African marine compounds as anticancer agents
- The interaction of some halogenated anaesthetic agents with hepatic drug metabolizing enzymes
- Ligand modification of Pluronic F108 for use in immobilized metal affinity separation of bio-macromolecules
- Genetic polymorphisms in the drug metabolizing genes and their roles in the development of oesophageal cancer
Author: Parker, Iqbal
- The development of a radiolabelled macromolecule as a therapeutic agent for the treatment of cancer
- Matrix-mediated regulation of type 1 collagen synthesis and degradation in cultured fibroblasts
- Characterisation of CIS- and trans-acting factors that regulate the human alpha 2(1) procollagen gene
- The regulation of type I collagen gene expression in stromal fibroblast by breast tumour cells
- The role of viral sequences in genetic aberrations and malignant transformation
- Differentially expressed genes in oesophageal cancer